The association between the ratio of monocytes: Lymphocytes and risk of tuberculosis among HIV-infected postpartum women

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue 5, 2014, Pages 573-575

  Naranbhai, Vivek ^a,b   Moodley, Dhayendre ^b   Chipato, Tsungai ^c   Stranix Chibanda, Lynda ^c   Nakabaiito, Clemensia ^d   Kamateeka, Moreen ^d   Musoke, Philippa ^d,e   Manji, Karim ^f   George, Kathleen ^g   Emel, Lynda M ^g   Richardson, Paul ^h   Andrew, Philip ^g   Fowler, Mary Glenn ^d,h   Fletcher, Helen ^a   McShane, Helen ^a   Coovadia, Hoosen M ⁱ   Hill, Adrian V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

^f MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^g FAMILY HEALTH INTERNATIONAL   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

HIV; Lymphocytes; ML ratio; Monocytes; Pregnancy; Tuberculosis

Indexed keywords

ADULT; ARTICLE; BLOOD CELL RATIO; CD4 LYMPHOCYTE COUNT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION RISK; LYMPHOCYTE; MAJOR CLINICAL STUDY; MONOCYTE; MONOCYTE LYMPHOCYTE RATIO; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; SECONDARY ANALYSIS; SOUTH AFRICA; TANZANIA; TUBERCULOSIS; UGANDA; ZIMBABWE; AFRICA; ANIMAL; COMPLICATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LEUKOCYTE COUNT; PREGNANCY; PUERPERIUM; YOUNG ADULT;

ADULT; AFRICA; ANIMALS; FEMALE; HIV INFECTIONS; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTES; MONOCYTES; POSTPARTUM PERIOD; PREGNANCY; RISK ASSESSMENT; TUBERCULOSIS; YOUNG ADULT;

EID: 84927599513     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/qai.0000000000000353     Document Type: Article

References (15)

1. Rangaka MX, Wilkinson KA, Glynn JR, et al. Predictive value of interferon-gamma release assays for incident active tuberculosis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:45-55.
2. Mathad JS, Gupta A. Tuberculosis in pregnant and postpartum women: epidemiology, management, and research gaps. Clin Infect Dis. 2012;55:1532-1549.
3. Govender T, Coovadia H. Eliminating mother to child transmission of HIV-1 and keeping mothers alive: recent progress. J Infect. 2014;68 (suppl 1):S57-S62.
4. Pillay T, Sturm AW, Khan M, et al. Vertical transmission of Mycobacterium tuberculosis in KwaZulu Natal: impact of HIV-1 co-infection. Int J Tuberc Lung Dis. 2004;8:59-69.
5. Fletcher H. Correlates of Risk of TB Disease in Infants Vaccinated With BCG. Tuberculosis: Understanding the Enemy, Keystone. Whistler, British Columbia, Canada: Whistler Conference Centre; 2013.
6. Naranbhai V, Kim S, Fletcher H, et al. The association between the ratio of monocytes: lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life. BMC Med. 2014;12:120.
7. Naranbhai V, Hill AV, Abdool Karim SS, et al. Ratio of monocytes to lymphocytes in peripheral blood identifies adults at risk of incident tuberculosis among HIV-infected adults initiating antiretroviral therapy. J Infect Dis. 2014;209:500-509.
8. Cunningham RS, Sabin FR, Sugiyama S, et al. The Role of the monocyte in tuberculosis. Bull Johns Hopkins Hosp. 1925;XXXVII:231-280.
9. Doan CA, Sabin FR. The relation of the tubercle and the monocyte: lymphocte ratio to resistance and susceptibility in tuberculosis. J Exp Med. 1930;52:113-152.
10. Sabin FR, Doan CA, Cunningham RS. Studies of the blood in experimental tuberculosis: the monocyte-lymphocyte ratio; the Anemia-Leucopenia phase. Transactions of the 22nd Annual Meeting of the National Tuberculosis Association; 1926(22):252-256.
11. Rogers PM. A study of the blood monocytes in children with tuberculosis. N Engl J Med. 1928;198:740-749.
12. Coovadia HM, Brown ER, Fowler MG, et al. Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomized, double-blind, placebo-controlled trial. Lancet. 2012;379:221-228.
13. Fowler MG, Coovadia H, Herron CM, et al. Efficacy and safety of an extended nevirapine regimen in infants of breastfeeding mothers with HIV-1 infection for prevention of HIV-1 transmission (HPTN 046):18-month results of a randomized, double-blind, placebo-controlled trial. J Acquir Immune Defic Syndr. 2014;65:366-374.
14. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of motherto-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomized trial. Lancet. 1999;354:795-802.
15. Watts DH, Brown ER, Maldonado Y, et al. HIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial. J Acquir Immune Defic Syndr. 2013;64:299-306.